Clinical Trials Browser

Phase NA × Fallopian Tube Neoplasms × Bevacizumab × Clear all

NCT01223235 2018-06-12

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Phase NA Completed

22 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms